Search Results - "Prieto, Miguel L."

Refine Results
  1. 1

    Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners by Undurraga, Juan, Bórquez-Infante, Ignacio, Crossley, Nicolás A, Prieto, Miguel L, Repetto, Gabriela M

    Published in Frontiers in pharmacology (15-04-2021)
    “…Use of pharmacogenetics (PGx) testing to guide clinical decisions is growing in developed countries. Published guidelines for gene-drug pair analysis are…”
    Get full text
    Journal Article
  2. 2

    Activation of neurotensin receptor type 1 attenuates locomotor activity by Vadnie, Chelsea A., Hinton, David J., Choi, Sun, Choi, YuBin, Ruby, Christina L., Oliveros, Alfredo, Prieto, Miguel L., Park, Jun Hyun, Choi, Doo-Sup

    Published in Neuropharmacology (01-10-2014)
    “…Intracerebroventricular administration of neurotensin (NT) suppresses locomotor activity. However, the brain regions that mediate the locomotor depressant…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Association of Bipolar Disorder With Major Adverse Cardiovascular Events: A Population-Based Historical Cohort Study by Foroughi, Moein, Medina Inojosa, Jose R., Lopez-Jimenez, Francisco, Saeidifard, Farzane, Suarez, Laura, Stokin, Gorazd B., Prieto, Miguel L., Rocca, Walter A., Frye, Mark A., Morgan, Robert J.

    Published in Psychosomatic medicine (01-01-2022)
    “…This study aimed to assess the association of bipolar disorder (BD) with risk of major adverse cardiac events (MACEs) after adjusting for established…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder by McElroy, Susan L, Crow, Scott, Blom, Thomas J, Biernacka, Joanna M, Winham, Stacey J, Geske, Jennifer, Cuellar-Barboza, Alfredo B, Bobo, William V, Prieto, Miguel L, Veldic, Marin, Mori, Nicole, Seymour, Lisa R, Bond, David J, Frye, Mark A

    Published in Journal of affective disorders (01-02-2016)
    “…Abstract Objective To determine prevalence rates and clinical correlates of current DSM-5 eating disorders in patients with bipolar disorder (BP). Methods…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors by Sanchez Ruiz, Jorge A., Coombes, Brandon J., Pendegraft, Richard S., Ozerdem, Aysegul, McElroy, Susan L., Cuellar-Barboza, Alfredo B., Prieto, Miguel L., Frye, Mark A., Winham, Stacey J., Biernacka, Joanna M.

    Published in Psychiatry research (01-05-2023)
    “…•Bipolar disorder is a chronic illness requiring lifelong psychotropic treatment.•Treatment typically involves switching or adding medications from different…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder by Erol, Almila, Winham, Stacey J, McElroy, Susan L, Frye, Mark A, Prieto, Miguel L, Cuellar-Barboza, Alfredo B, Fuentes, Manuel, Geske, Jennifer, Mori, Nicole, Biernacka, Joanna M, Bobo, William V

    Published in Bipolar disorders (01-09-2015)
    “…Objectives To examine the independent effects of sex on the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I…”
    Get full text
    Journal Article